Molecular Partners Ag (MOLN) FCF Margin (QoQ) (2021 - 2026)
Molecular Partners Ag (MOLN) FCF Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - |
| 10 | Molecular Partners Ag | 163.25 Mn | 163.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.44 Mn |
| Dec 31, 2025 | -13.14 Mn |
| Sep 30, 2025 | 41.68 Mn |
| Jun 30, 2025 | -17.09 Mn |
| Mar 31, 2025 | -120.67 Mn |
| Dec 31, 2024 | 120.66 Mn |
| Sep 30, 2024 | 209.17 Bn |
| Jun 30, 2024 | -209.17 Bn |
| Mar 31, 2024 | 22,844.00 |
| Dec 31, 2023 | -116.56 Mn |
| Sep 30, 2023 | 117.19 Mn |
| Jun 30, 2023 | -713,820.00 |
| Mar 31, 2023 | -7,827.00 |
| Dec 31, 2022 | 8,467.00 |
| Sep 30, 2022 | -129,275.00 |
| Jun 30, 2022 | 128,635.00 |
| Mar 31, 2022 | -116.00 |
| Dec 31, 2021 | -147.61 Mn |
| Sep 30, 2021 | 147.61 Mn |
| Jun 30, 2021 | 534.00 |